For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251202:nRSB7677Ja&default-theme=true
RNS Number : 7677J Caspian Sunrise plc 02 December 2025
Caspian Sunrise PLC
("Caspian Sunrise" or the "Company")
Issue of shares
The Board of Caspian Sunrise is pleased to confirm that a total of 2,121,210
new ordinary Caspian Sunrise PLC shares have been issued credited as fully
paid in respect of bonus payments to non-board members based on an issue price
of 5p per share.
Application will be made for the New Shares to be admitted to trading on AIM,
which is expected to occur on or around 5 December 2025 ("Admission"). The
New Shares will rank pari passu in all respects with the Company's existing
ordinary shares currently traded on AIM.
Following Admission, the Company's issued share capital will
comprise 2,356,306,042 ordinary shares of 1 pence each. This number will
represent the total voting rights in the Company and may be used by
shareholders as the denominator for the calculation by which they can
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the Financial Conduct
Authority's Disclosure and Transparency Rules.
Contacts:
Zeus +44 (0) 203 829 5000
James Joyce
James Bavister
Andrew de Andrade
This announcement has been posted to:
www.caspiansunrise.com/investors (http://www.caspiansunrise.com/investors)
The person responsible for arranging the release of this announcement on
behalf of the Company is Clive Carver, Chairman of the Company.
This announcement has been posted to:
www.caspiansunrise.com/investors (http://www.caspiansunrise.com/investors)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEFLFVDFRLLIIE
Copyright 2019 Regulatory News Service, all rights reserved